67. Polycystic kidney disease Clinical trials / Disease details

Clinical trials : 216 / Drugs : 219 - (DrugBank : 50) / Drug target genes : 39 - Drug target pathways : 151

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02119052 (ClinicalTrials.gov)	January 2009	17/4/2014	Effects of Somatostatin on Liver in ADPKD	Effect of Long-acting Somatostatin on Liver in Autosomal Dominant Polycystic Kidney Disease	Autosomal Dominant Polycystic Kidney Disease	Drug: octeotride;Drug: placebo	Federico II University	NULL	Completed	18 Years	N/A	Both	35	Phase 2/Phase 3	NULL
2	NCT02119013 (ClinicalTrials.gov)	January 2009	17/4/2014	Effects of Somatostatin on ADPKD Heart	EFFECT OF SOMATOSTTIN ON EARLY DIASTOLIC LEFT VENTRICULAR FUNCTION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A MATCHED-COHORT, SPECKLE-TRACKING ECHOCARDIOGRAPHIC STUDY	Autosomal Dominant Polycystic Kidney Disease;Glomerular Filtration Rate > 40 ml/Min	Drug: Octeotride;Drug: Placebo	Federico II University	NULL	Completed	18 Years	80 Years	Both	35	Phase 2/Phase 3	NULL